ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HEMO Hemogenyx Pharmaceuticals Plc

1.585
-0.023 (-1.43%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.023 -1.43% 1.585 1.57 1.60 1.60 1.56 1.60 5,559,012 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.51 18.04M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.61p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £18.04 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.51.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 1176 to 1197 of 13425 messages
Chat Pages: Latest  57  56  55  54  53  52  51  50  49  48  47  46  Older
DateSubjectAuthorDiscuss
02/2/2020
20:48
Purple. You see my history. I was not a fan of dave.
I was following Badger for a long time as he speak sense.
But we should not deny the fact that most of points raised by Dave were spot on.

I’m not losing patience but now after reading last 2 year RNS, I think hemo is going nowhere. But I won’t sell my share in loss and neither I will buy more.

I’m just annoyed that I should have done more research before investing here.

marie1980
02/2/2020
20:43
'Aim is all speculation, nothing is guaranteed'.

EXACTLY!

Though only one of us has called it right so far..

davevt
02/2/2020
20:39
anyone can easily talk down any company listed on AIM. AIM is all speculation.nothing is guaranteed.
what youre saying is just drivel.that is why im bothering to post,because youre just dribbling on talking down a good stock for no apparent reason.

what a waste of time or you eh?

purple11
02/2/2020
20:35
why are you so fascinated by HEMO?
purple11
02/2/2020
20:34
I see you had zero rebuttal to the b.s I just called you out on.

THAT'S why I bother posting.

Run along to your moderated board now 😅

davevt
02/2/2020
20:32
why do you bother posting?
i post because im bored.

purple11
02/2/2020
20:27
I cant figure you out at all! why don't you just show a little patience and believe a little!youve been completely taken in by davet and that is v foolish imho.davet wont make you any money!!
purple11
02/2/2020
20:25
Completely agree.

HEMO should fly with IND news or phase 1 trial. I would be delighted to hear Phase 1 trial which is pending since long.

Even IND news should generate excitement here but even their website says pre clinical.. annoying. Last year I was expecting for IND news

marie1980
02/2/2020
20:18
nfx traded over 40m cap two months later on positive results.

.i can wait 2 months.imm ended up a 400m cap company before it collapsed.i rest my case.i can wait for that!

you just had a spike yo sell your shares!youre sounding more a fool everyday imho.

purple11
02/2/2020
19:52
Purple,

To answer your question, NFX is small
Pharma which went to trial 1 with circa 7m.

Correct me but even IMM was circa 10 M when it went to 1st trial.

marie1980
02/2/2020
19:50
You haven't even seen data from this company to show what they are even saying works in vitro or vivo, other than 'it works'. Where's the data, what did it work on, how well did it work, did it work but come back, what's the dosing, side effects, eficiacy, cell count drop etc...all stuff you usually see in drug related rns. Nope all you see from this company is 'our drug works' and then a load of rampy tweets. Remember these words....



Let’s accept this... since 2 year we hear this things again n again.

This is blunt but so true. Still no reply from hemo about subsidiary. I don’t want to sell hemo with losses so I will wait for another “spike”.

marie1980
02/2/2020
19:13
show me a pharma stock trading at 7mcap going into a phase 1 trial

pls don't keep embarrassing yourself on a public forum.LOL

purple11
02/2/2020
19:06
Thanks Dave...we are not worthy of your great intelligence...

What share are you invested in...you never say

johntopdog
02/2/2020
19:03
Here's the low down of what will happen.

Next step they might get positive in vivo results of their new treatment. It is gonna push the share price up much? Not really, same as last time.

You have a year for this to happen before they do another placing.

Let's say they manage to start trials. Is this gonna push the price up? no, because it would be expected and you have no idea if it's going to work anyway.

How long will trials take? Years.

Anyone gonna buy them out in the meantime? Not unless trials are positive, after years.

This is a drug in the first stages of infancy. Trade this share if you wish but make sure you're out before another placing.

davevt
02/2/2020
18:58
What share are you invested in Dave...please tell oh great guru
johntopdog
02/2/2020
18:52
Purple, did you just advise people to buy shares?

And there we have it people...

davevt
02/2/2020
18:50
Purple, why do you believe anything written in an rns?

Why would you take any of it as true? Rns's are there to report news, this company uses them for ramping.

'Clinical readiness' means nothing if you have no means of funding it, and doesn't mean it's GOING TO WORK 😅

You haven't even seen data from this company to show what they are even saying works in vitro or vivo, other than 'it works'. Where's the data, what did it work on, how well did it work, did it work but come back, what's the dosing, side effects, eficiacy, cell count drop etc...all stuff you usually see in drug related rns.

Nope all you see from this company is 'our drug works' and then a load of rampy tweets.

Remember these words....

davevt
02/2/2020
13:56
no one takes the thread seriously.
purple11
02/2/2020
11:22
P.s. A broken clock is right twice a day!
delano1967
02/2/2020
11:09
"clinical readiness" are the two words that ppl should note here.

not the constant waffling of some teenager.

as we move towards IND and a development agreement this price will never be seen again.take advantage is my opinion.

purple11
02/2/2020
11:01
fear of missing out syndrome.its all it can be.

on the next rise davet will disappear again sure as night turns to day.

purple11
02/2/2020
11:00
They are in it together.... Marie and Dave.... if you keep saying something will go down it ultimately will and you will be right at some point because nothing goes up in a straight line. A post by Marie complaining of investing on other people’s thoughts is absolute rubbish. Only 3 or 4 investors I take notice of on here and it’s not any of these two. GL
delano1967
Chat Pages: Latest  57  56  55  54  53  52  51  50  49  48  47  46  Older

Your Recent History

Delayed Upgrade Clock